BPC-157 and Rosuvastatin Interaction

Synergistic
Mechanism-based 50% confidence

BPC-157 and Rosuvastatin have a synergistic interaction with 50% confidence. BPC-157 reduces inflammation while Rosuvastatin promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Rosuvastatin

HMG-CoA Reductase Inhibitor | Statin for Lipid Management

Rosuvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for hepatic cholesterol synthesis. By blocking this enzyme, rosuvastatin reduces intracellular cholesterol in hepatocytes, which triggers upregulation of LDL receptor expression on the liver cell surface.

Half-life: ~19 hours Typical dose: 5-20 mg/day cardiovascular
hepatotoxiclipid disruptingteratogenic
View full profile

Combined Organ Load

Blood Vessels
low
Heart
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, Rosuvastatin). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Rosuvastatin?

Yes, BPC-157 and Rosuvastatin can generally be taken together. BPC-157 reduces inflammation while Rosuvastatin promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.

Is BPC-157 and Rosuvastatin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Rosuvastatin?

BPC-157 reduces inflammation while Rosuvastatin promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.

How should I time BPC-157 and Rosuvastatin?

BPC-157 has a half-life of <30 minutes and Rosuvastatin has a half-life of ~19 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Rosuvastatin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.